← Back to all bills
Nevada · AB 555 · 2025Enacted

Insulin cost-sharing cap

Caps out-of-pocket cost-sharing for a 30-day supply of prescription insulin at $35 for people on state-regulated commercial health insurance plans, making Nevada the 28th state with such a cap.

Status
Signed into law
Status date
2025-06-13
State
Nevada
Session year
2025

Topics

Drug Pricing & AccessInsurance & Coverage

Want to weigh in on this bill?

Find your representatives and let them know how this issue affects you.

Contact your representatives

Related bills

Washington · SB 5981

340B Prescription Drug Discount Program

Enacted

Strengthens state oversight of the 340B program so discounted drug pricing intended for safety-net clinics and hospitals actually reaches patients.

Drug Pricing & Access
Washington · HB 2613

Compounded Medication Safety

Pending Verification

Sets safety standards for pharmacies that compound custom medications to reduce contamination and dosing errors.

Drug Pricing & AccessPatient Rights & Privacy
Washington · SB 5326

Emergency Insulin Supplies

Pending Verification

Allows pharmacists to dispense a short emergency supply of insulin to patients who run out and can't immediately reach their doctor.

Drug Pricing & AccessEmergency Care